Diaz–BuxoJ.A., CrawfordT.Peritonitis and antibiotic therapy in patients on cycler peritoneal dialysis—an update.Adv Perit Dial2000; 16: 229–32.
2.
VergerC., LuzarM.A.In vitro study of CAPD Y-line system.Adv CAPD1986; 2: 160–4.
3.
de FijterC.W.H., VerbrughH.A., OeP.L., PetersE.D.J., van der MeulenJ., DonkerA.J.M.Peritoneal defenses in continuous ambulatory versus continuous cyclic peritoneal dialysis.Kidney Int1992; 42: 947–50.
4.
WrengerE., BaumannC., BehrendM., ZamoreE., SchindlerR., BrunkhorstR.Peritoneal mononuclear cell differentiation and cytokine production in intermittent and continuous automated peritoneal dialysis.Am J Kidney Dis1998; 31: 234–41.
Diaz–BuxoJ.A., WalkerP.J., BurgessW.P., ChandlerJ.T., FarmerC.D., HoltK.L.Current status of CCPD in the prevention of peritonitis.Adv CAPD1986; 2: 145–8.
10.
RottembourgJ., BrouardR., IssadB., AllouacheM., NguyenJ., MontassineM.C.Prevention of peritonitis during continuous ambulatory peritoneal dialysis. Value of disconnectable systems (French).Presse Med1988; 17: 1349–53.
11.
HolleyJ.L., BernardiniJ., PirainoB.Continuous cycling peritoneal dialysis is associated with lower rates of catheter infections than continuous ambulatory peritoneal dialysis.Am J Kidney Dis1990; 16: 133–6.
12.
LevyM., BalfeJ.W., GearyD., Fryer–KeeneS P.Factors predisposing and contributing to peritonitis during chronic peritoneal dialysis in children: a ten-year experience.Perit Dial Int1990; 10: 263–9.
13.
de FijterC.W.H., OeP.L., NautaJ.J.P., van der MeulenJ., ter WeeP.M., SnoekF.J.A prospective, randomized study comparing the peritonitis incidence of CAPD and Y-connector (CAPD-Y) with continuous cyclic peritoneal dialysis (CCPD).Adv Perit Dial1991; 7: 186–9.
14.
GahrmaniN., Gorban–BrennanN., KligerA.S., FinkelsteinF.O.Infection rates in end-stage renal disease patients treated with CCPD and CAPD using the UltraBag system.Adv Perit Dial1995; 11: 164–6.
15.
ViglinoG., GandolfoC., VirgaG., CavalliP.L.Role of automated peritoneal dialysis within a peritoneal dialysis program.Adv Perit Dial1995; 11: 134–8.
Rodríguez–CarmonaA., FontánM.P., FalcónT.G., RiveraC.F., ValdésF.A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis.Perit Dial Int1999; 19: 253–8.
19.
Perez–FontánM., Rodríguez–CarmonaA., García– FalcónT., Fernández–RiveraC., ValdésF.Incidence of peritonitis (P) and exit site infection (ESI) in CAPD and automated PD (APD). A comparative study (Abstract).Perit Dial Int1999; 19(Suppl 1): S35.
20.
HuangJ.W., HungK.Y., YenC.J., WuK.D.A., TsaiT.J.Comparison of infectious complications in peritoneal dialysis patients using either a twin-bag system or automated peritoneal dialysis.Nephrol Dial Transplant2001; 16: 604–7.
SheminD., MaazD., St. PierreD, KahnSI, ChazanJA.Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients.Am J Kidney Dis1999; 34: 14–20.
ManleyH.J., BailieG.R., FryeR., HessL.D., McGoldrickM.D.Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.J Am Soc Nephrol2000; 11: 1310–16.
